Chapel Hill CRS

Running trials

• Not yet recruiting

  A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

  NCT06987318· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

  NCT05099965· Phase 2· Source

• Completed

  B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

  NCT04193189· Phase 3· Source

• Completed

  Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1

  NCT03739996· Phase 2· Source

• Completed

  The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

  NCT03635788· Phase 3· Source

• Completed

  Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

  NCT02720094· Phase 2/3· Source